Melatonan

Melatonan

SCHEMBL29473785

CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 20/20 0.67
▸ MC3R P41968 9/20 0.67
▸ MC5R P33032 6/20 0.67
▸ MC1R Q01726 5/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19473991 0.98 MC4R (0.66) MC4RMC3RMC5RMC1R
SCHEMBL10307917 0.98 MC4R (0.66) MC4RMC3RMC5RMC1R
SCHEMBL13063946 0.98 MC4R (0.66) MC4RMC3RMC5RMC1R
SCHEMBL19473791 0.98 MC4R (0.66) MC4RMC3RMC5RMC1R
SCHEMBL19473989 0.98 MC4R (0.66) MC4RMC3RMC5RMC1R
SCHEMBL19473806 0.98 MC4R (0.64) MC4RMC3RMC5RMC1R
SCHEMBL13063933 0.98 MC4R (0.64) MC4RMC3RMC5RMC1R
SCHEMBL10307923 0.98 MC4R (0.64) MC4RMC3RMC5RMC1R
SCHEMBL10307921 0.98 MC4R (0.64) MC4RMC3RMC5RMC1R
SCHEMBL10307956 0.98 MC4R (0.64) MC4RMC3RMC5RMC1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220281919-A1 pH-SENSITIVE CYCLIC PEPTIDES UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES 2022-09-08 — — US disclosed
US-11274126-B2 pH-sensitive cyclic peptides UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2022-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274126-B2 pH-sensitive cyclic peptides VIP, PHLPP1, PHLPP2 MC4R 2841/4885MC3R 2388/4885MC5R 3164/4885
US-20220281919-A1 pH-SENSITIVE CYCLIC PEPTIDES VIP, PHLPP1, PHLPP2 MC4R 2841/4885MC3R 2388/4885MC5R 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback